300975 Product Name: Combinatie van binimetinib en encorafenib, beide in alle vormen zoals beschermd door het basisoctrooi
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 31/05/2022 | Outgoing Correspondence | Letter confirmation withdrawal | 1 | /5/0/4/8/8/0800388405/docs/300975_20_483766l193.pdf | ||
| 30/05/2022 | SPC Documents | Withdrawal SPC | 1 | /5/0/4/8/8/0800388405/docs/300975_19_supplprotectioncertificate20220530054958303.pdf | ||
| 03/05/2022 | SPC Documents | Mail SPC | 4 | /5/0/4/8/8/0800388405/docs/300975_21_supplprotectioncertificate20220504120105314.pdf | ||
| 25/03/2022 | SPC Documents | Annex SPC | 1 | /5/0/4/8/8/0800388405/docs/300975_2_supplprotectioncertificate20220325042949152.pdf | ||
| 25/03/2022 | SPC Documents | Annex SPC | 1 | /5/0/4/8/8/0800388405/docs/300975_3_supplprotectioncertificate20220325042949171.pdf | ||
| 25/03/2022 | Incoming Correspondence Paper | Accompanying letter incoming document | 15 | /5/0/4/8/8/0800388405/docs/300975_4_incomingcorrespondencepaper20220325042949083.pdf | ||
| 25/03/2022 | SPC Documents | Annex SPC | 1 | /5/0/4/8/8/0800388405/docs/300975_5_supplprotectioncertificate20220325042949131.pdf | ||
| 25/03/2022 | SPC Documents | Annex SPC | 2 | /5/0/4/8/8/0800388405/docs/300975_6_supplprotectioncertificate20220325042949190.pdf | ||
| 25/03/2022 | SPC Documents | Annex SPC | 1 | /5/0/4/8/8/0800388405/docs/300975_7_supplprotectioncertificate20220325042949209.pdf | ||
| 25/03/2022 | SPC Documents | Annex SPC | 1 | /5/0/4/8/8/0800388405/docs/300975_8_supplprotectioncertificate20220325042949112.pdf | ||
| 12/01/2022 | Outgoing Correspondence | Letter to applicant | 2 | /5/0/4/8/8/0800388405/docs/300975_9_455610l173.pdf | ||
| 21/03/2019 | Outgoing Correspondence | Confirmation receipt request | 1 | /5/0/4/8/8/0800388405/docs/300975_17_260762l174.pdf | ||
| 15/03/2019 | SPC Documents | Annex SPC | 2 | /5/0/4/8/8/0800388405/docs/300975_0_supplprotectioncertificate20190321105029635.pdf | ||
| 15/03/2019 | SPC Documents | Marketing Authorization SPC | 3 | /5/0/4/8/8/0800388405/docs/300975_1_supplprotectioncertificate20190320040112334.pdf | ||
| 15/03/2019 | SPC Documents | Summary of the characteristics of the product | 29 | /5/0/4/8/8/0800388405/docs/300975_10_supplprotectioncertificate20190320040112647.pdf | ||
| 15/03/2019 | Application Form | First filed application form | 3 | /5/0/4/8/8/0800388405/docs/300975_11_applicationform20190320040112051.pdf | ||
| 15/03/2019 | SPC Documents | Annex SPC | 18 | /5/0/4/8/8/0800388405/docs/300975_12_supplprotectioncertificate20190321105029717.pdf | ||
| 15/03/2019 | SPC Documents | Annex SPC | 2 | /5/0/4/8/8/0800388405/docs/300975_13_supplprotectioncertificate20190320040112504.pdf | ||
| 15/03/2019 | SPC Documents | Annex SPC | 14 | /5/0/4/8/8/0800388405/docs/300975_14_supplprotectioncertificate20190320040112574.pdf | ||
| 15/03/2019 | SPC Documents | Marketing Authorization SPC | 3 | /5/0/4/8/8/0800388405/docs/300975_15_supplprotectioncertificate20190320040112267.pdf | ||
| 15/03/2019 | SPC Documents | Accompanying letter SPC | 4 | /5/0/4/8/8/0800388405/docs/300975_16_supplprotectioncertificate20200603025435797.pdf | ||
| 15/03/2019 | SPC Documents | Summary of the characteristics of the product | 27 | /5/0/4/8/8/0800388405/docs/300975_18_supplprotectioncertificate20190320040112404.pdf |